Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lower Extremity | 31 | 2023 | 1151 | 2.930 |
Why?
|
Vascular Surgical Procedures | 31 | 2023 | 1473 | 2.600 |
Why?
|
Ischemia | 25 | 2020 | 1911 | 1.980 |
Why?
|
Peripheral Arterial Disease | 23 | 2020 | 1184 | 1.920 |
Why?
|
Endovascular Procedures | 22 | 2022 | 1973 | 1.790 |
Why?
|
Limb Salvage | 26 | 2020 | 433 | 1.460 |
Why?
|
Peripheral Vascular Diseases | 12 | 2012 | 550 | 1.410 |
Why?
|
Blood Vessel Prosthesis Implantation | 21 | 2020 | 1384 | 1.250 |
Why?
|
Veins | 7 | 2018 | 769 | 1.100 |
Why?
|
Femoral Artery | 9 | 2023 | 843 | 1.080 |
Why?
|
Angioplasty | 12 | 2020 | 364 | 1.080 |
Why?
|
Popliteal Artery | 6 | 2023 | 317 | 0.990 |
Why?
|
Angioplasty, Balloon | 11 | 2018 | 653 | 0.960 |
Why?
|
Vascular Grafting | 4 | 2018 | 142 | 0.940 |
Why?
|
Varicose Veins | 3 | 2013 | 154 | 0.880 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2022 | 1181 | 0.880 |
Why?
|
Endarterectomy, Carotid | 7 | 2013 | 546 | 0.570 |
Why?
|
Graft Occlusion, Vascular | 6 | 2015 | 548 | 0.560 |
Why?
|
Stents | 20 | 2023 | 3276 | 0.540 |
Why?
|
Chi-Square Distribution | 27 | 2018 | 3510 | 0.500 |
Why?
|
Intermittent Claudication | 5 | 2016 | 309 | 0.490 |
Why?
|
Blood Vessel Prosthesis | 9 | 2019 | 933 | 0.490 |
Why?
|
Arterial Occlusive Diseases | 4 | 2012 | 793 | 0.460 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2283 | 0.450 |
Why?
|
Leg | 6 | 2013 | 1110 | 0.450 |
Why?
|
Diabetes Complications | 5 | 2007 | 1359 | 0.440 |
Why?
|
Wound Healing | 11 | 2020 | 2781 | 0.410 |
Why?
|
Venous Insufficiency | 1 | 2012 | 103 | 0.400 |
Why?
|
Time Factors | 48 | 2021 | 40054 | 0.390 |
Why?
|
Diabetic Foot | 3 | 2010 | 352 | 0.390 |
Why?
|
Vascular Patency | 16 | 2018 | 885 | 0.380 |
Why?
|
Aortic Rupture | 5 | 2016 | 310 | 0.380 |
Why?
|
Saphenous Vein | 4 | 2020 | 531 | 0.340 |
Why?
|
Kidney Failure, Chronic | 5 | 2016 | 2536 | 0.340 |
Why?
|
Diabetic Angiopathies | 2 | 2005 | 820 | 0.330 |
Why?
|
Quality Indicators, Health Care | 6 | 2016 | 1831 | 0.330 |
Why?
|
Carotid Stenosis | 4 | 2023 | 854 | 0.330 |
Why?
|
Diabetes Mellitus | 9 | 2018 | 5724 | 0.320 |
Why?
|
Treatment Outcome | 59 | 2022 | 62966 | 0.320 |
Why?
|
Creatinine | 4 | 2013 | 1916 | 0.310 |
Why?
|
Risk Factors | 54 | 2022 | 72145 | 0.310 |
Why?
|
Inguinal Canal | 2 | 2005 | 69 | 0.290 |
Why?
|
Decision Support Techniques | 4 | 2017 | 1952 | 0.280 |
Why?
|
Arteries | 2 | 2008 | 1118 | 0.280 |
Why?
|
Retrospective Studies | 53 | 2021 | 77098 | 0.270 |
Why?
|
Polytetrafluoroethylene | 4 | 2002 | 233 | 0.260 |
Why?
|
Internship and Residency | 2 | 2018 | 5774 | 0.260 |
Why?
|
Carotid Arteries | 4 | 2002 | 952 | 0.260 |
Why?
|
Kaplan-Meier Estimate | 13 | 2017 | 6534 | 0.260 |
Why?
|
Patient Selection | 11 | 2019 | 4214 | 0.250 |
Why?
|
Carotid Artery Diseases | 4 | 2013 | 882 | 0.250 |
Why?
|
Aged, 80 and over | 41 | 2020 | 57683 | 0.250 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2013 | 685 | 0.240 |
Why?
|
Wound Infection | 2 | 2017 | 240 | 0.240 |
Why?
|
Aged | 67 | 2023 | 162944 | 0.240 |
Why?
|
Logistic Models | 22 | 2018 | 13403 | 0.240 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 656 | 0.240 |
Why?
|
Kidney Transplantation | 2 | 2013 | 4246 | 0.240 |
Why?
|
Heart Function Tests | 1 | 2005 | 330 | 0.240 |
Why?
|
Multivariate Analysis | 19 | 2018 | 12242 | 0.230 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1066 | 0.230 |
Why?
|
Ultrasonography, Interventional | 4 | 2019 | 1483 | 0.230 |
Why?
|
Risk Assessment | 27 | 2021 | 23320 | 0.230 |
Why?
|
Prosthesis-Related Infections | 3 | 2016 | 538 | 0.210 |
Why?
|
Tibial Arteries | 1 | 2002 | 57 | 0.200 |
Why?
|
Odds Ratio | 15 | 2018 | 9846 | 0.200 |
Why?
|
Reoperation | 13 | 2018 | 4200 | 0.190 |
Why?
|
Postoperative Complications | 18 | 2018 | 15244 | 0.180 |
Why?
|
Databases, Factual | 9 | 2021 | 7716 | 0.180 |
Why?
|
Constriction, Pathologic | 3 | 2015 | 1095 | 0.180 |
Why?
|
Vascular Diseases | 1 | 2008 | 1155 | 0.180 |
Why?
|
Male | 74 | 2023 | 349538 | 0.180 |
Why?
|
Quality Improvement | 4 | 2016 | 3738 | 0.180 |
Why?
|
Female | 76 | 2023 | 379592 | 0.170 |
Why?
|
Humans | 95 | 2023 | 742088 | 0.170 |
Why?
|
Middle Aged | 53 | 2021 | 213127 | 0.170 |
Why?
|
Spinal Fusion | 1 | 2008 | 1234 | 0.170 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1844 | 0.170 |
Why?
|
Foot | 3 | 2010 | 528 | 0.170 |
Why?
|
Groin | 1 | 2019 | 102 | 0.170 |
Why?
|
Tunica Intima | 3 | 1999 | 464 | 0.160 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 645 | 0.160 |
Why?
|
Critical Illness | 6 | 2017 | 2665 | 0.160 |
Why?
|
Surgical Wound Infection | 5 | 2016 | 1538 | 0.150 |
Why?
|
Length of Stay | 13 | 2018 | 6294 | 0.150 |
Why?
|
Learning Curve | 1 | 2018 | 200 | 0.150 |
Why?
|
Data Collection | 2 | 2016 | 3339 | 0.140 |
Why?
|
Aneurysm, Ruptured | 3 | 2012 | 452 | 0.140 |
Why?
|
Proportional Hazards Models | 13 | 2017 | 12344 | 0.140 |
Why?
|
Angiography | 2 | 2020 | 1636 | 0.140 |
Why?
|
Aorta | 3 | 2022 | 2057 | 0.140 |
Why?
|
Anastomosis, Surgical | 3 | 1998 | 985 | 0.130 |
Why?
|
Endothelial Growth Factors | 2 | 1999 | 694 | 0.130 |
Why?
|
Databases as Topic | 7 | 2011 | 475 | 0.130 |
Why?
|
Retreatment | 2 | 2016 | 604 | 0.130 |
Why?
|
Endoleak | 1 | 2016 | 101 | 0.130 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 344 | 0.130 |
Why?
|
Boston | 11 | 2017 | 9305 | 0.130 |
Why?
|
Lymphokines | 2 | 1999 | 949 | 0.130 |
Why?
|
Celiac Artery | 1 | 2015 | 68 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1239 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 1996 | 281 | 0.130 |
Why?
|
Silver Compounds | 1 | 2014 | 22 | 0.130 |
Why?
|
Chronic Disease | 10 | 2020 | 9144 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 640 | 0.120 |
Why?
|
Myocardial Infarction | 6 | 2018 | 11690 | 0.120 |
Why?
|
Treatment Failure | 4 | 2019 | 2615 | 0.120 |
Why?
|
Cyclins | 1 | 1996 | 601 | 0.120 |
Why?
|
Meglumine | 1 | 2014 | 149 | 0.120 |
Why?
|
Anesthesia, General | 1 | 2021 | 1164 | 0.120 |
Why?
|
Recurrence | 7 | 2018 | 8333 | 0.120 |
Why?
|
Voluntary Health Agencies | 1 | 2013 | 39 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1038 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1999 | 1504 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2015 | 1780 | 0.110 |
Why?
|
Perioperative Care | 1 | 2001 | 997 | 0.110 |
Why?
|
Stockings, Compression | 1 | 2012 | 37 | 0.110 |
Why?
|
Alginates | 1 | 2014 | 250 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 741 | 0.110 |
Why?
|
Polyesters | 1 | 2014 | 363 | 0.110 |
Why?
|
Bandages | 1 | 2014 | 267 | 0.110 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1080 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2001 | 1541 | 0.110 |
Why?
|
Registries | 9 | 2018 | 8077 | 0.110 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 131 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 250 | 0.100 |
Why?
|
Autoantigens | 1 | 1996 | 891 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1499 | 0.100 |
Why?
|
Polyethylenes | 1 | 2014 | 283 | 0.100 |
Why?
|
Renal Artery Obstruction | 1 | 2013 | 248 | 0.100 |
Why?
|
Sclerotherapy | 1 | 2012 | 175 | 0.100 |
Why?
|
Health Status Disparities | 2 | 2013 | 1794 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7153 | 0.100 |
Why?
|
Stroke | 8 | 2018 | 9963 | 0.100 |
Why?
|
Occupational Health | 1 | 2017 | 809 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1638 | 0.100 |
Why?
|
Genes | 1 | 1995 | 1892 | 0.090 |
Why?
|
Lung Diseases | 1 | 2021 | 1884 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15056 | 0.090 |
Why?
|
Staphylococcal Infections | 2 | 2013 | 1398 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 665 | 0.090 |
Why?
|
Research Design | 2 | 2016 | 5979 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1095 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2195 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2001 | 2145 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1967 | 0.090 |
Why?
|
Viscera | 1 | 2010 | 139 | 0.090 |
Why?
|
Resistin | 1 | 2010 | 170 | 0.090 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 2866 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2017 | 1927 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1996 | 1517 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2001 | 1873 | 0.080 |
Why?
|
Survival Rate | 8 | 2013 | 12773 | 0.080 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2009 | 97 | 0.080 |
Why?
|
Dogs | 4 | 1998 | 3910 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2013 | 865 | 0.080 |
Why?
|
Hemostasis, Surgical | 1 | 2008 | 128 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3151 | 0.080 |
Why?
|
Renal Artery | 1 | 2010 | 398 | 0.080 |
Why?
|
United States | 19 | 2018 | 69693 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 964 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2017 | 1794 | 0.070 |
Why?
|
Insulin | 2 | 2018 | 6575 | 0.070 |
Why?
|
RNA, Messenger | 4 | 1998 | 13029 | 0.070 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15530 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1581 | 0.070 |
Why?
|
Hyperplasia | 4 | 1999 | 1183 | 0.070 |
Why?
|
Body Mass Index | 4 | 2017 | 12695 | 0.070 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1150 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1380 | 0.070 |
Why?
|
Thinness | 1 | 2009 | 479 | 0.070 |
Why?
|
Gene Expression | 2 | 1998 | 7790 | 0.070 |
Why?
|
E2F Transcription Factors | 1 | 2006 | 274 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2167 | 0.070 |
Why?
|
Punctures | 2 | 2019 | 372 | 0.070 |
Why?
|
Curriculum | 1 | 2018 | 3589 | 0.070 |
Why?
|
Quality of Life | 2 | 2016 | 12730 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 762 | 0.060 |
Why?
|
Adult | 16 | 2015 | 213712 | 0.060 |
Why?
|
Clinical Competence | 2 | 2018 | 4681 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2145 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6249 | 0.060 |
Why?
|
Adiponectin | 1 | 2010 | 1099 | 0.060 |
Why?
|
Patient Readmission | 2 | 2018 | 3111 | 0.060 |
Why?
|
Comorbidity | 6 | 2018 | 10372 | 0.060 |
Why?
|
Proteinuria | 1 | 2006 | 657 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2005 | 314 | 0.060 |
Why?
|
Hospital Mortality | 6 | 2013 | 5310 | 0.060 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6891 | 0.060 |
Why?
|
Suture Techniques | 1 | 2008 | 797 | 0.060 |
Why?
|
Peer Review, Research | 2 | 2016 | 329 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2121 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 183 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3937 | 0.050 |
Why?
|
Upper Extremity | 1 | 2007 | 648 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 101 | 0.050 |
Why?
|
Hematoma | 2 | 2014 | 755 | 0.050 |
Why?
|
Heart Failure | 2 | 2005 | 10856 | 0.050 |
Why?
|
Follow-Up Studies | 10 | 2013 | 39004 | 0.050 |
Why?
|
Asymptomatic Diseases | 2 | 2016 | 552 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2008 | 1296 | 0.050 |
Why?
|
New England | 2 | 2016 | 1021 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 209 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 1996 | 5851 | 0.050 |
Why?
|
Incidence | 6 | 2016 | 20928 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1873 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7276 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4775 | 0.050 |
Why?
|
Aneurysm | 1 | 2004 | 339 | 0.050 |
Why?
|
Endarterectomy | 2 | 2013 | 195 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.050 |
Why?
|
Emergency Medical Services | 2 | 2009 | 1914 | 0.040 |
Why?
|
Age Factors | 5 | 2016 | 18355 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1999 | 772 | 0.040 |
Why?
|
Overweight | 1 | 2010 | 2366 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2495 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 9941 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3869 | 0.040 |
Why?
|
Extremities | 1 | 2004 | 865 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3199 | 0.040 |
Why?
|
Sex Factors | 4 | 2013 | 10392 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2527 | 0.040 |
Why?
|
Morbidity | 1 | 2003 | 1767 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3203 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 971 | 0.040 |
Why?
|
Prospective Studies | 7 | 2023 | 53187 | 0.040 |
Why?
|
Survival Analysis | 5 | 2013 | 10248 | 0.040 |
Why?
|
Consensus | 2 | 2016 | 2935 | 0.040 |
Why?
|
Life Tables | 1 | 2017 | 370 | 0.040 |
Why?
|
Radiation Monitoring | 1 | 2017 | 97 | 0.040 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1486 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 1999 | 11363 | 0.040 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4322 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 3336 | 0.030 |
Why?
|
Patient Discharge | 3 | 2013 | 3300 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 12705 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 192 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2245 | 0.030 |
Why?
|
Captopril | 1 | 1996 | 272 | 0.030 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1431 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3766 | 0.030 |
Why?
|
Hemorrhage | 2 | 2019 | 3461 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2267 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 4983 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 144 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 148 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 164 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 644 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1086 | 0.030 |
Why?
|
Texas | 1 | 2014 | 392 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2017 | 924 | 0.030 |
Why?
|
Muscle Proteins | 1 | 1999 | 1159 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 425 | 0.030 |
Why?
|
Thrombosis | 2 | 2019 | 2966 | 0.030 |
Why?
|
Cohort Studies | 5 | 2012 | 40450 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 694 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 688 | 0.030 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 117 | 0.030 |
Why?
|
Graft Survival | 3 | 2010 | 3733 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1995 | 318 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15194 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1950 | 0.030 |
Why?
|
Aneurysm, False | 1 | 2014 | 276 | 0.030 |
Why?
|
Workload | 1 | 2017 | 849 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1995 | 2049 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3418 | 0.020 |
Why?
|
Vascular System Injuries | 1 | 2014 | 250 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2924 | 0.020 |
Why?
|
Life Expectancy | 1 | 2017 | 1183 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2789 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7901 | 0.020 |
Why?
|
Aortography | 1 | 2012 | 431 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 1999 | 3502 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 154 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3582 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19862 | 0.020 |
Why?
|
Gadolinium | 1 | 2014 | 951 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
American Heart Association | 1 | 2013 | 1055 | 0.020 |
Why?
|
Embolectomy | 1 | 2009 | 120 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 29010 | 0.020 |
Why?
|
Electrocardiography | 2 | 2014 | 6440 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13256 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1469 | 0.020 |
Why?
|
Adipokines | 1 | 2010 | 318 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 2255 | 0.020 |
Why?
|
Device Removal | 1 | 2013 | 652 | 0.020 |
Why?
|
Base Sequence | 2 | 1999 | 12797 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1503 | 0.020 |
Why?
|
Radiography | 2 | 2012 | 7010 | 0.020 |
Why?
|
RNA | 1 | 1997 | 2747 | 0.020 |
Why?
|
History, 21st Century | 1 | 2013 | 1533 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7167 | 0.020 |
Why?
|
Risk | 1 | 1999 | 9679 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1164 | 0.020 |
Why?
|
Animals | 6 | 2005 | 168561 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 687 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1392 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6171 | 0.020 |
Why?
|
Rats | 2 | 2005 | 24265 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20774 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2123 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3667 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8300 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2502 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 13853 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2970 | 0.010 |
Why?
|
Hospital Costs | 1 | 2010 | 980 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 458 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1364 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1239 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3215 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2885 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3728 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1440 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 238 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2013 | 2706 | 0.010 |
Why?
|
Materials Testing | 1 | 2005 | 865 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2005 | 1902 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1839 | 0.010 |
Why?
|
Adolescent | 3 | 2008 | 85649 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 453 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8621 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 2003 | 445 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5295 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7721 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1188 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8662 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 11695 | 0.010 |
Why?
|
Young Adult | 3 | 2012 | 56350 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 135 | 0.010 |
Why?
|
Population Surveillance | 1 | 2009 | 2616 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2170 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1999 | 251 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 934 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2857 | 0.010 |
Why?
|
DNA Probes | 1 | 1998 | 560 | 0.010 |
Why?
|
Mitral Valve | 1 | 2005 | 1484 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5978 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1999 | 625 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2948 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1999 | 18112 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14720 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13921 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4393 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1999 | 1333 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2117 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 12017 | 0.010 |
Why?
|
Blotting, Western | 1 | 1999 | 5180 | 0.010 |
Why?
|
Up-Regulation | 1 | 1999 | 4211 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20086 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1999 | 19223 | 0.000 |
Why?
|